Trials / Conditions / T-cell Non-Hodgkin's Lymphoma
T-cell Non-Hodgkin's Lymphoma
4 registered clinical trials studyying T-cell Non-Hodgkin's Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma NCT05013372 | Peking University People's Hospital | EARLY_Phase 1 |
| Unknown | Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma NCT02987244 | Peking Union Medical College Hospital | Phase 1 / Phase 2 |
| Terminated | Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute L NCT00742495 | Mundipharma Research Limited | Phase 1 / Phase 2 |
| Terminated | A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lym NCT00655668 | Celgene | Phase 2 |